Neutrophil extracellular traps (NETs) are implicated in autoimmunity, but how they are generated and their roles in sterile inflammation remain unclear. Ribonucleoprotein immune complexes (RNP ICs), inducers of NETosis, require mitochondrial reactive oxygen species (ROS) for maximal NET stimulation. After RNP IC stimulation of neutrophils, mitochondria become hypopolarized and translocate to the cell surface. Extracellular release of oxidized mitochondrial DNA is proinflammatory in vitro, and when this DNA is injected into mice, it stimulates type I interferon (IFN) signaling through a pathway dependent on the DNA sensor STING. Mitochondrial ROS are also necessary for spontaneous NETosis of low-density granulocytes from individuals with systemic lupus erythematosus. This was also observed in individuals with chronic granulomatous disease, who lack NADPH oxidase activity but still develop autoimmunity and type I IFN signatures. Mitochondrial ROS inhibition in vivo reduces disease severity and type I IFN responses in a mouse model of lupus. Together, these findings highlight a role for mitochondria in the generation not only of NETs but also of pro-inflammatory oxidized mitochondrial DNA in autoimmune diseases. 
Neutrophils contribute to inflammation by interacting with innate and adaptive immune cells 1 and by releasing proteolytic enzymes and reactive intermediates 2 . NET formation, a cell death pathway characterized by extrusion of chromatin bound to cytosolic and granular content 3 , has been implicated in autoimmune disorders. Previous in vitro studies of type I IFN-primed neutrophils from individuals with systemic lupus erythematosus (SLE) showed that ribonucleoprotein-containing immune complexes (RNP ICs), prevalent in lupus, can induce NETosis 4 . Also, low-density granulocytes (LDGs), a distinct pro-inflammatory neutrophil subset found in individuals with SLE, exhibit enhanced spontaneous NETosis when examined ex vivo 5 . NETs opsonized by autoantibodies can stimulate plasmacytoid dendritic cells to synthesize IFN-α. NETs also promote vasculopathy and inflammasome activation [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Furthermore, the presence of modified autoantigens in NETs may contribute to breaking immune tolerance in predisposed hosts 14 .
NETs are induced by many pathogens and by sterile stimuli including cytokines, ICs, and autoantibodies 15 ; in vitro, they can also be induced by phorbol myristate acetate (PMA) or calcium ionophores 16 . Although the molecular pathways leading to NETosis remain incompletely characterized, both histone citrullination 17 and ROS production seem to be necessary. Superoxide synthesis leading to NETosis has been considered to originate mainly from NADPH oxidase-dependent pathways 3 . Diphenyleneiodonium (DPI), an inhibitor of NADPH oxidase, nitric oxide synthase (NOS), and cytochrome P450 reductase, decreases NETosis 10, 13 . Whereas these observations suggested that NADPH oxidase pathways are required for NETosis, most studies have used DPI concentrations that also inhibit other ROS generators that are responsible for pro-inflammatory oxidant synthesis 18 . It is therefore unclear whether ROS generated by NADPH oxidase-independent pathways affects NETosis and its inflammatory properties in disease states. Because mitochondria are a potent source of ROS, and mitochondrial DNA (mtDNA) has recently been implicated in inflammatory responses [19] [20] [21] , we examined the role of mitochondria in NETosis and immune stimulatory effects in SLE.
RESULTS

RNP IC-mediated NETosis is dependent on mitochondrial ROS
To explore the relative contribution of NADPH oxidase and the mitochondrial electron chain in ROS generation and NETosis, we stimulated normal neutrophils with PMA or RNP ICs ( Supplementary  Fig. 1 ) in the presence of ROS inhibitors. DPI almost completely inhibited PMA-and RNP IC-induced NETosis ( Fig. 1a and Supplementary  Fig. 2 ). By using MitoSOX Red, a triphenylphosphonium-linked dihydroethidium compound that concentrates within mitochondria and fluoresces red when oxidized by ROS, we observed mitochondrial ROS generation after neutrophil activation by RNP ICs and, to a lesser extent, by PMA, but not by the Toll-like receptor (TLR) agonist R848 (Fig. 1b) . Supporting this result, thenoyltrifluoroacetone (TTFA, a specific inhibitor of mitochondrial respiration) reduced IC-induced, but not PMA-induced, NETosis (Fig. 1a) . To determine whether NADPH-oxidase was necessary for RNP IC-mediated NETosis, two specific inhibitors, apocynin and VAS2870 (ref. 22) , were used and shown to inhibit RNP IC-and PMA-induced NET formation (Fig. 1a) . These results suggest sequential activation in which, in normal-density granulocytes (NDGs), NADPH oxidase is required as a priming factor for mitochondrial ROS, similarly to what has been described for angiotensin II (ref. 23) . As in control neutrophils, NDGs from individuals with SLE induced NETs in a mitochondrial ROSdependent manner when activated with RNP ICs (Fig. 1c) . Thus, RNP IC-induced ROS production in healthy and lupus neutrophils is, at least in part, generated by mitochondrial respiration and attenuation of this reduced NETosis.
RNP ICs induce oxidized mtDNA release
Upon mitochondrial damage by ROS, mitochondria lose membrane potential and undergo either mitophagy or extrusion to protect cells against excessive ROS production [24] [25] [26] . Considering the prominent induction of mitochondrial ROS by RNP ICs, we examined RNP ICs' effect on mitochondria. Most control NDGs had high mitochondrial membrane potential (Fig. 1d) , which decreased after RNP IC stimulation (Fig. 1e) . Hypopolarized mitochondria lined the plasma membrane, in contrast to the evenly distributed hyperpolarized mitochondria (Fig. 1d,e) . RNP ICs increased the frequency of neutrophils with reduced mitochondrial potential (Fig. 1f) . Because protein kinase C (PKC)-mediated mitochondrial ROS may participate in the loss of mitochondrial membrane potential 24, 25 , we added MitoTEMPO (a mitochondria-specific superoxide scavenger) or the PKC inhibitor chelerythrine chloride to RNP IC-activated neutrophils, and we observed that they both reduced RNP IC-mediated mitochondrial hypopolarization (Fig. 1f) .
Flow cytometry and confocal microscopy revealed that RNP ICs, but not the TLR8 agonist R848, induced mitochondrial mobilization to the neutrophil cell surface (Fig. 2a,b) . Detection of the mitochondrial outer membrane protein TOM20 on the cell surface of non-permeabilized propidium iodide-negative cells was pronase sensitive, indicating that the TOM20-specific antibodies recognized a cell surface-accessible protein (Supplementary Fig. 3a) . To exclude the possibility of binding of extruded mitochondria-containing NETs to the neutrophil cell surface, which would increase TOM20-specific membrane staining, we treated neutrophils with DNase. Cell surface levels of TOM20 were DNase insensitive, suggesting that they are unlikely to be the consequence of cell surface-deposited NETs (Supplementary Fig. 3a) .
To examine potentially adverse effects of mitochondrial ROS generation, we examined whether RNP IC-induced DNA oxidation using 8-Oxo-2′-deoxyguanosine (8-OHdG)-specific antibodies. After RNP IC activation, there was strong 8-OHdG staining both on the neutrophil cell surface and on the extruded NETs ( Fig. 2b-d) . Because antibodies against TOM20 co-localized with 8-OHdG, these findings suggest that most oxidation occurred on mitochondrial rather than chromosomal DNA. As mitochondria induced ROS after RNP IC exposure (Fig. 1b) , we asked whether mitochondrialgenerated ROS were necessary for DNA oxidation. Indeed, both DPI and TTFA reduced DNA 8-OHdG content (Fig. 2e) . To conclusively determine if the released oxidized DNA was of mitochondrial origin, we immunoprecipitated total oxidized DNA using anti-8-OHdG and quantified the relative abundance of mitochondrial (16S; officially known as MT-RNR2) and chromosomal (18S; officially known as RNA18S5) DNA by qPCR. An increased ratio of 16S:18S DNA was detected in the total oxidized DNA, suggesting it is enriched for mtDNA (Fig. 2f) . Oxidized DNA was still enriched in mtDNA, even when we incubated NETs with proteinase K to remove histones and when chromosomal DNA was sheared to generate small fragments (data not shown). Although RNP ICs and PMA primarily released we used a two-sided paired t-test; *P < 0.05, **P < 0.01 and ***P < 0.001. P values are adjusted for multiple comparisons; five for a, three for c and two for f, using Bonferroni correction.
npg chromosomal DNA during NETosis, only activation by RNP ICs increased mtDNA release (Fig. 2g) . Inhibition of mitochondrial ROS reduced the relative amount of mtDNA as compared to chromosomal DNA in released NETs (Fig. 2h) . In support of mtDNA extrusion, intracellular mtDNA levels were decreased concomitantly with increased NET-derived mtDNA levels ( Supplementary Fig. 3b ). Therefore, upon RNP IC activation, mitochondria are mobilized to the cell surface, where they release oxidized mtDNA in a mitochondrial ROS-dependent manner.
NET-bound oxidized mtDNA is pro-inflammatory Oxidized genomic DNA, induced by ultraviolet irradiation or H 2 O 2 , is more resistant to degradation by the exonuclease TREX1, leading to cyclic GMP-AMP synthase (cGAS)-STING (also known as transmembrane protein 173 (TMEM173))-dependent type I IFN and interleukin (IL)-6 induction 27 . mtDNA is also pro-inflammatory, exerting its effects via TLR9, inflammasome activation 20, 21 and by engaging the cGAS-STING pathway through a Bcl-2 homologous antagonist/killer (Bak)/Bcl-2-like protein 4 (Bax) dependent process 19 . To examine the inflammatory potential of oxidized mtDNA, we added NET-derived 8-OHdG − and 8-OHdG + DNA to human peripheral blood mononuclear cells (PBMCs) and incubated them overnight. Similarly to a recent report 27 , but using a pathophysiologically relevant stimulus, we observed that 8-OHdG + DNA was a more potent inducer of IFNB1 (encoding interferon β1) and other pro-inflammatory cytokine mRNA (Fig. 3a) . We observed similar results after transfection of the monocytic cell line THP1 with 8-OHdG + DNA at the mRNA (Fig. 3b) and protein levels (data not shown). To investigate whether the increased inflammatory properties of oxidized mtDNA were secondary to oxidation or to DNA-intrinsic properties, we isolated genomic and mtDNA from several different species (human, herring, mouse) and cell types, and we then oxidized the DNA in vitro through UV irradiation 27 . We found that 8-OHdG content was increased in all DNA samples upon UV irradiation, and that it was associated with the induction of the IFN-stimulated gene (ISG) CXCL10, independent of species or cellular origin (genomic or mtDNA) ( Supplementary Fig. 4a-e) . Thus, our data suggest that the extent of DNA oxidation, and not intrinsic differences between mitochondrial and genomic DNA, is a key factor promoting the interferogenic capacity of DNA, which is consistent with prior reports [27] [28] [29] .
Although oxidized mtDNA acted as a potent inflammatory stimulus in PBMCs and THP1 cells, it did not induce neutrophil activation (either alone or in complex with the 8-OHdG-specific antibody), despite being internalized (Supplementary Fig. 5 ).
To determine the in vivo biological relevance of oxidized mtDNA in inflammation and the DNA-sensor pathway responsible for the recognition of oxidized mtDNA externalized in NETs, we examined ISG induction in wild-type (WT) and (Fig. 3c) , but it was impaired in the Myd88 −/− mice, consistent with the specificity of the cGAS-STING pathway to recognize double-stranded, but not single-stranded DNA 30 . Thus, the released oxidized mtDNA was highly pro-inflammatory and supported ISG induction through the STING pathway.
Mitochondrial ROS drive pro-inflammatory NETosis in SLE LDGs
Mitochondrial superoxide production was increased in LDGs from individuals with SLE as compared to healthy control NDGs or autologous lupus NDGs, as determined by MitoSOX staining. MitoSOX co-localized with the mitochondrial complex V subunit D, indicating that enhanced superoxide production by SLE LDGs is of mitochondrial origin (Fig. 4a-c) . We found that mitochondrial superoxide production was also necessary for spontaneous LDG NETosis, as it was decreased by MitoTEMPO ( Fig. 4d-f) .
DNA spontaneously released by lupus LDG NETs was highly enriched for mtDNA and for 8-OHdG-modified DNA as compared to NETs induced by other stimuli in healthy control neutrophils ( Fig. 4g,h ). These SLE LDG-derived NETs were more inflammatory in that they potently stimulated ISGs in THP1 cells (Fig. 4i) . Overall, SLE LDGs spontaneously release NETs enriched in oxidized mtDNA in a mitochondria-derived superoxide-dependent manner, leading to enhanced pro-inflammatory and interferogenic potential.
Because lupus LDGs produced increased mitochondrial-derived superoxide and spontaneous NET release ex vivo, we examined serologic evidence of ongoing NETosis in vivo. We found that individuals with SLE had increased amounts of myeloperoxidase (MPO):DNA, human neutrophil elastase (HNE):DNA and citrullinated histone: MPO complexes in plasma compared to controls, suggesting in vivo NETosis. Furthermore, peroxidase activity in lupus serum correlated with disease activity, as measured according to the SLE Disease Activity Index 2000 (SLEDAI-2K) (Supplementary Fig. 6 ).
Mitochondrial ROS drive pro-inflammatory NETosis in CGD LDGs
Individuals with chronic granulomatous disease (CGD) have mutations in subunits of the NADPH oxidase complex, resulting in defects in superoxide production, and they have an increased predisposition to autoimmune diseases, including SLE. Whereas CGD NDGs can exhibit a relative resistance to NETosis 31 , the potential contribution of LDGs and mitochondrial-derived ROS to immunogenic NET formation in this disease has not been addressed.
As in SLE, LDGs were increased in subjects with CGD as compared to controls (Supplementary Table 1 ). CGD LDGs showed enhanced spontaneous NETosis (Fig. 5a,b) comparable to SLE LDGs. Spontaneous NETosis by CGD LDGs was inhibited by MitoTEMPO, demonstrating that these cells relied on mitochondrial ROS to form NETs (Fig. 5a-c) . Indeed, CGD LDGs showed enhanced mitochondrial superoxide synthesis (Fig. 5d) . In contrast, the inhibition of other ROS sources, such as MPO, with 3-amino,12,4-triazole or NO with l-N G -monomethyl-l-arginine, did not abrogate NETosis in CGD LDGs (data not shown). NETs from subjects with CGD had an increased ratio of mtDNA:chromosomal DNA, as compared to healthy controls (Fig. 5e) . Higher amounts of MPO:DNA and HNE:DNA complexes were detectable in CGD plasma as compared to control plasma (Fig. 5f,g ), suggesting enhanced in vivo NETosis. Levels of HNE:DNA complexes in CGD plasma correlated with antinuclear antibodies (ANAs), although these values did not reach statistical significance (Supplementary Table 1 ; R = 0.47, P = 0.06). Overall, these findings suggest that mitochondrial ROS synthesis is sufficient to generate NETs in the npg absence of NADPH oxidase activity, and that it may promote NETs enriched in mtDNA in CGD. Recent evidence indicates that individuals with CGD develop a type I IFN signature 32 . As we observed that oxidized mtDNA upregulates type I IFNs, we evaluated serum type I IFN activity in the CGD cohort that displayed enhanced LDG NETosis, and we assessed correlations between ISGs and features of autoimmunity. Compared to controls, 72.7% of individuals with CGD had increased serum type I IFN activity (defined in Supplementary Fig. 7 ). An association between ISGs and systemic autoimmunity and/or positive autoantibodies (ANAs, antiextractable nuclear antigens and/or anti-neutrophil cytoplasmic antibodies) was also detectable (P = 0.02, by Fisher's exact test). Indeed, 92.3% of CGD subjects with clinical autoimmunity and/or positive autoantibodies had high type I serum activity. Thus, increased LDG mitochondrial ROS production and ex vivo and in vivo NETosis are associated with enhanced type I IFN activity in CGD. 
npg
Mitochondrial ROS scavengers suppress lupus-like disease in vivo To confirm whether mitochondrial ROS promotes lupus-like disease, MitoTEMPO was continuously administered prophylactically for 7 weeks via subcutaneous pump, starting at 10 weeks of age, to MRL/lpr lupus-prone mice. MitoTEMPO-treated mice had decreased spontaneous NETosis by bone marrow neutrophils (Fig. 6a) , less proteinuria and renal IC deposition (Fig. 6b,c) , as well as decreased serum anti-dsDNA ( Fig. 6c-f) . Treatment also reduced splenocyte ISG induction and inflammatory cytokine mRNA production, but not inflammasome-related genes, when compared to vehicle-treated MRL/lpr mice (Fig. 6g) . That the inflammasome pathway was not affected by MitoTEMPO treatment was confirmed by quantifying caspase-1 and IL-18 activation in kidney protein extracts (Fig. 6h) . Thus, prophylactic inhibition of mitochondrial ROS suppresses NETosis, type I IFN responses and lupus-like autoimmune disease in mice.
DISCUSSION
Previous studies indicate that lupus lymphocytes display elevated mitochondrial ROS synthesis 33 . By studying ROS generation during NETosis, we identified two novel roles for the mitochondria in SLE: first, the capability of mitochondrial ROS to drive NETosis after RNP IC stimulation in vitro and in the pro-inflammatory LDG subset in lupus and CGD subjects ex vivo; and second, the release of oxidized mtDNA with potent pro-inflammatory and interferogenic properties.
The in vivo relevance of our findings is strongly supported by the detection of circulating complexes that are likely to be derived from NETs in SLE and individuals with CGD, as well as by the reduction of lupus severity in a mouse model after systemic inhibition of mitochondrial ROS. Recent evidence implicates aberrant NETosis and/or impaired NET clearance in the pathogenesis of autoimmune disorders, including SLE 4,9,10 . These observations have been supported by mouse studies in which pharmacologic inhibition of NETosis ameliorates lupus, atherosclerosis and thrombosis 11, 12 . In apparent contrast to these observations, lupus-prone MRL/lpr mice that are deficient in Cybb (cytochrome b-245, beta polypeptide, also known as Nox2), and which therefore lack functional NADPH oxidase, develop a worsening lupus phenotype when compared to mice that are not deficient in Cybb 34 . Similarly, individuals with CGD also have a propensity to develop autoimmune conditions, including SLE. Because ROS generation is necessary for NETosis in most contexts, and NET formation is reduced in CGD subjects 3, 31, 35 , it was suggested that NETosis may not contribute to SLE pathogenesis 34 . However, NADPH oxidase has pleiotropic immunologic functions 36 and is not the sole source of neutrophil ROS. Indeed, mitochondria are one of the major sites of ROS generation, and enhanced mitochondrial ROS has been associated with chronic inflammatory conditions 37 . Our findings indicate that mitochondrial ROS production can be sufficient to generate NETs even in the absence of functional NADPH oxidase. 18 For statistical analysis, we used unpaired t-test for normal distribution (a,c,f) and Mann-Whitney (f,g) for non-normalized data *P < 0.05, ***P < 0.001, ****P < 0.0001. Although homeostatic mechanisms protect the genome from ROS-induced damage, NETosis is characterized by nuclear membrane disintegration that allows for chromatin decondensation and exposure of genomic DNA to ROS. mtDNA is particularly vulnerable to oxidant damage, as it lies close to ROS production sites and lacks protection by histones 38, 39 . NETosis may therefore be a crucial event that allows for the oxidation of genomic and mitochondrial nucleic acids. Notably, oxidized mtDNA, either externalized by RNP IC stimulation or from spontaneously formed LDG NETs, induced a striking increase in inflammatory cytokine production in target cells in a STING-dependent manner.
Lupus LDGs are a distinct pro-inflammatory neutrophil subset characterized by increased NET formation 5 . In contrast to NDGs, mitochondrial ROS appear to be key drivers of LDG NETosis, as treatment with specific mitochondrial ROS scavengers led to a marked attenuation of this process. In addition, LDGs showed increases in mitochondrial ROS production when compared to NDGs. The reason for this enhancement is unclear, but cytokines, autoantibodies and/or ICs present in SLE may alter the bone marrow niche and/or promote the release of immature granulocytes endowed with enhanced mitochondrial mass. Conversely, LDGs may represent a subpopulation of mature activated neutrophils 5, 8 that are capable of enhanced mitochondrial ROS synthesis. Whether the recent associations between lupus susceptibility and variants of or mutations in mitochondrial or NADPH-subunit genes promote enhanced mitochondrial ROS synthesis and release of mtDNA by lupus neutrophils remains to be determined 40, 41 .
CGD offers an opportunity to study the consequences of reduced NADPH oxidase activity on neutrophil functions dependent on oxidants, such as NETosis. Our observations of enhanced NETosis in CGD differ from previous reports that CGD neutrophils were resistant to NETosis. Those studies assessed NDG responses to specific stimuli and did not evaluate LDGs 42 . Enhanced mitochondrial ROS production by CGD LDGs may be a compensatory mechanism related to a lack of NADPH oxidase activity. Indeed, in response to exogenous signals, macrophages that are deficient in the NADPH oxidase phox subunit p47 increase mitochondrial ROS production, and this is linked to cell death and inflammation 43 . Potential mechanisms include recruitment of mitochondria to phagosomes and interactions with tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), as well as autophagy inhibition with retention of dysfunctional mitochondria 43, 44 . As such, the absence of functional NADPH oxidase may force cells to use mitochondria as alternative ROS sources, thus promoting dysfunctional NETosis and cell survival disruptions.
The mechanisms driving increased inflammation and predisposition to autoimmunity in CGD involve activation of both innate and adaptive immunity. Our data suggest that a key component of innate immune activation leading to autoimmunity observed in CGD, as in SLE, is mitochondrial ROS-dependent NETosis of LDGs, which promotes externalization of pro-inflammatory oxidized mtDNA and subsequent activation of STING and/or TLR-dependent type I IFN synthesis. The enhanced levels of circulating neutrophil granular proteins, pro-inflammatory cytokines and type I IFNs reported in CGD 32, 45, 46 is very similar to what we observed was induced in target cells exposed to mitochondrial-enriched NET DNA. Other mechanisms that were previously implicated in chronic inflammation observed in CGD 6,47-50 could synergize with neutrophil dysregulation to promote amplification of inflammatory responses. NETs may also have important roles in limiting inflammation 51 and, as with many other cellular processes, their pro-or anti-inflammatory roles may be context-dependent and require further investigation.
The implication of enhanced NETosis driven by mitochondrial ROS was supported by in vivo experiments in lupusprone mice, showing attenuation of autoimmunity features and clinical phenotype when exposed to a mitochondrial ROS scavenger. This is of relevance because various mitochondrial ROS inhibitors are currently being tested in clinical settings in other diseases, and they could potentially be studied in the context of systemic autoimmunity as potential therapeutic targets 52, 53 . Mitochondria therefore appear to have an important, previously unappreciated role in immunemediated NETosis; we suggest that mitochondrial ROS and release of oxidized mtDNA may be instrumental in initiating or perpetuating autoimmunity and the type I IFN signature observed in individuals with SLE and CGD.
METHODS
Methods and any associated references are available in the online version of the paper.
ONLINE METHODS
Human samples, inclusion and exclusion criteria, and study approval. Blood from individuals with a diagnosis of CGD or SLE, or from healthy controls was obtained at the Clinical Center, National Institutes of Health (NIH) and the Rheumatology Clinic, University of Washington Medical Center. All individuals signed informed consent in respective IRB-approved protocols (University of Washington; HSD number 39712; NIH 94-AR-0066 and 05-I-0213). SLEaffected individuals fulfilled American College of Rheumatology revised diagnostic criteria and over 90% were females 54 . CGD-affected individuals had diagnosis confirmation by cytochrome c reduction assay (for residual superoxide activity) 55 , protein expression by western blotting, and genetic sequencing. Samples were available from the time point of the clinical visit with corresponding information on SLE disease activity, assessed by SLEDAI-2K criteria. Demographic and clinical characteristics individuals with CGD are shown in Supplementary Table 1 . As pre-established criteria, any individual with CGD receiving interferon-γ was excluded. Individuals with CGD and SLE with recent or active infections were also excluded.
Isolation of neutrophils and NETs. To isolate neutrophils, heparinized blood was layered on Polymorphprep (Axis-Shield, Dundee, UK) density gradient according to the manufacturer's instructions, or on Ficoll as described previously 8, 10 . Red blood cells were lysed with hypertonic solution, and neutrophils were resuspended in neutrophil medium (RPMI 1640 (Life Technologies, Waltham, MA) supplemented with 0.01 M HEPES (Gibco, Gaithersburg, MD), MEM non-essential amino acids (Thermo Scientific, Waltham, MD) and 2% autologous serum. LDGs were purified from PBMC fractions using negative selection method as previously described 8 . LDG purity was confirmed by flow cytometry staining for CD14-FITC, CD15-PE, and CD10-APC (catalog numbers 325610, 301906, and 312210, respectively, Biolegend, San Diego, CA).
Normal-density neutrophils (NDGs) (1 × 10 6 cells/ml) were incubated in poly-l-lysine coated tissue culture plates with or without presence of indicated inhibitors (all from Sigma, St. Louis, MO): DPI (25 µM,), MitoTEMPO (10 µM), rotenone (10 µM), thenoyltrifluoroacetone (1 µM), VAS2870 (5 µM) or apocynin (100 µM) for 1 h and activated with RNP ICs (IgG, purified from three individuals with SLE selected for the presence of a high titer of anti-RNP antibodies, mixed with SmRNP (Arotec, New Zealand) used at final concentration of 10 µg/ml, Supplementary Fig. 1 ) or PMA (20 nM). In some experiments, we used purified 8-OHdG DNA (2.5 µg/ml) combined with anti-8-OHdG antibodies (StressMarq Biosciences, Victoria, Canada; clone 15A3). NETs were detached for 30 min at 37 °C with micrococcal nuclease (0.3 U/ml, Fisher Scientific, Pittsburgh, PA) diluted in nuclease buffer containing 10 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 2 mM CaCl 2 and 50 mM NaCl. In some experiments, NETs were induced by incubating NDGs with the A23187 calcium ionophore (25 µM, EMD Millipore, Billerica, MA) for 90 min followed by detachment of NETs by DNase I treatment (100 U/ml, Roche, Basel, Switzerland). The NET-containing supernatant was stored at −80 °C until analyzed. For LDGs, no stimulation was used before quantifications or NET isolation, since these cells already spontaneously formed NETs 5 .
Quantification of NETs. Detached NETs were quantified by analyzing Sytox Green (Life Technologies) intensity by plate reader (Synergy 2, BioTek, Winooski, VT). In some experiments, NDGs or LDGs were plated in 96-well plates (Corning Fisher Scientific) in the presence or absence of NET-inducing stimuli and an inhibitor: A23187 (25 µM), 3-AT (10 mM, Fisher Scientific), l-NMMA (200 µM, Abcam, Cambridge, MA) or MitoTEMPO (10 µM, Sigma) for 2 h. Sytox Orange (500 nM, Life Technologies) was used to detect extracellular DNA, and PicoGreen (1:500, Life Technologies) for total DNA. Fluorescence was quantified using the BIOTEK plate reader Synergy HTX. As A23187 displays auto-fluorescence in the green wavelength range when membrane-bound, the data for NDGs is presented displaying only Sytox Orange, whereas the ratio of external/total DNA was used for spontaneous LDG NET formation.
Visualization and quantification of NETs by fluorescence microscopy. Neutrophils, seeded in coverslips or coverslip chambers were stimulated for 90 min at 37 °C, fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, followed by 0.5% gelatin for 20 min. Cells were stained with antibodies directed against neutrophil elastase (1:1,000, ab21595, Abcam) Quantification ROS production and neutrophil activation. The total ROS detection kit and MitoSOX (2.5 µM) were used according to the manufacturer's instructions (Enzo Life Sciences and Life Technologies, NY). Lupus LDGs and control NDGs were incubated with either MitoSox (5 µM) or MitoTracker green FM (100 nM) and cells were quantified by flow cytometry following the manufacturer's instructions for concentration and timing and using BD color matched beads for compensation (catalog number: 552843 BD Biosciences, San Diego, CA). Mitochondria were also analyzed by flow cytometry using TOM20 antibodies (Novus Biologicals) and Mitosox (Life Technologies). In some experiments, neutrophils were treated with pronase (2 mg/ml, Calbiochem, San Diego, CA) or DNase (50 µg/ml, Roche) 30 min before addition of TOM20. Neutrophil activation was assessed by cell surface expression of CD66b (clone G10F5, BioLegend). Phagocytosis of 8-OHdG ICs was analyzed by flow cytometry and immunofluorescence microscopy upon incubation of neutrophils with Alexa Fluor-conjugated 8-OHdG ICs (2.5 µg/ml, pre-formed as described above) for 30 min. Phagocytosis index was determined as phagocytosed ICs per neutrophil and field of observation. Data were analyzed by FlowJo (Tree Star, Inc., Ashland, OR). For all analyses, isotype antibodies or fluorescently labeled beads were used as negative controls.
8-OHdG ELISA. For detection of 8-OHdG-modified nucleotides, 250 ng of DNA was added to poly-l-lysine-coated plates (0.01%) and incubated at 4 °C overnight. The wells were washed twice in PBS and blocked with PBS containing 1% BSA for 2 h at room temperature. Oxidized nucleotides were recognized by a biotinylated mouse-anti-human 8-OHdG antibody (StressMarq Biosciences) used at 0.5 µg/ml for 2 h at room temperature, followed by incubation with horseradish peroxidase (HRP)-conjugated streptavidin. The assay was developed with TMB (3,3′,5,5′-tetramethylbenzidine), and absorbance was analyzed at 450 nm.
8-OHdG and TOM20 fluorescence microscopy. Neutrophils seeded over coverslip chambers (LabTek) pre-coated with poly-l-lysine 0.01% (Sigma) were fixed in 4% paraformaldehyde overnight and permeabilized in 0.2% Triton for 10 min. Oxidized DNA was detected by biotinylated 8-OHdG antibody (StressMarq Biosciences) used at 1 µg/ml and mitochondria (TOM20) was detected using rabbit-anti-human mAb EPR15581 (1:250, ab186734, Abcam), followed by incubation with Alexa Fluor 555 and Alexa Fluor 488 donkey anti-mouse and rabbit-conjugated antibodies at 1:250 (Invitrogen) and Hoechst 1:1,000. Cells were resuspended in Prolong and visualized with a Zeiss LSM780 laser confocal fluorescence microscope. Images were acquired using the microscope's associated software.
Immunoprecipitation of oxidized DNA. Neutrophils (4 × 10 6 cells/ml), stimulated with RNP ICs (40 µg/ml) at a final volume of 500 µl, were cultured in 24-well plates as described above for 3 h. After addition of micrococcal nuclease (0.3 U/ml) for 30 min at 37 °C, cell-free supernatants were incubated with anti-8-OHdG antibodies (5 µg/ml) coupled to protein G beads (25 µλ; Thermo Scientific) at 4 °C overnight. After centrifugation and extensive washing, non-8-OHdG DNA (supernatant) as well as 8-OHdG + DNA (bound to antibody-bead complex), were treated with proteinase K (0.5 µg/ml, Thermo Scientific) for 4 h at 56 °C. DNA was isolated by phenol chloroform extraction. DNA-containing solution was mixed with an equal volume of phenol:chloroform: npg isoamyl alcohol (25:24:1, United States Biochemical Corporation, Cleveland, OH) and centrifuged at 10,000g for 2 min to extract the DNA. The isolated DNA fraction was resuspended in ethanol with 75 mM sodium acetate (Sigma) and allowed to precipitate at −20 °C for 16 h. After repeated washes in ethanol, DNA was resuspended in water.
Quantitative real-time PCR of mitochondrial and chromosomal genes. 8 ng of DNA, isolated as described above using phenol chloroform, were mixed with SYBR green master mix (Thermo Scientific) and primers (50 nM) for 16S (forward: 5′-CGC ATA AGC CTG CGT CAG ATC AA-3′, reverse: 5′-TGT GTT GGG TTG ACA GTG AGG G-3′) or 18S (forward: 5′-GTA ACC CGT TGA ACC CC A TT-3′, reverse: 5′-CCA TCC AAT CGG TAG TAG CG-3′) at a final volume of 20 µl. Activation of enzyme at 95 °C for 15 min was followed by 40 cycles with 95 °C for 15 s and 60 °C for 60 s.
Assessment of mitochondrial membrane potential. Neutrophils were incubated in the presence of stimuli for 4 h, as described in other sections. During the last 30 min of incubation, JC-1 (5 µg/ml, Enzo Life Sciences) was added. Cells were washed twice and analyzed by fluorescence microscopy or flow cytometry. In some experiments, chelerythrine chloride (Sigma, 2 µM), was added one hour before addition of stimuli to the cells.
Quantification of peroxidase activity. Serum samples (20 µl, collected from SLE subjects) were incubated with TMB (BD Biosciences) at a final volume of 100 µl for 30 min at room temperature. The reaction was ended by addition of 2 N sulfuric acid. The absorbance was analyzed by a plate reader at 450 nm. Values are reported as absorbance units with background subtracted or as mU/ml using HRP (Sigma) as standard curve.
Quantification of MPO activity.
A 96-well plate was coated with 2 µg/ml mouse monoclonal anti-human MPO (AbD Serotec, Kidlington, UK; clone 2C7) in PBS overnight. After blocking for 2 h with 1% bovine serum albumin (BSA) in PBS, serum samples or detached NETs were added and incubated for 2 h at room temperature. TMB or Sytox Green was used for detection as described above.
MPO:DNA complexes. High-binding 96-well ELISA microplates were incubated overnight at 4 °C with mouse anti-human MPO (clone 4A4; AbD Serotec) in coating buffer from the Cell Death Detection ELISA kit (cat# 11544675001; Roche). After blocking with 1% BSA (cat# A7906; Sigma) in PBS, plates were incubated overnight at 4 °C with 10% human plasma in blocking buffer, washed, and anti-DNA-POD (clone MCA-33; Roche) was added for 1.5 h at room temperature. Following incubation, TMB substrate (cat# T0440; Sigma) was added and absorbance was measured at 450 nm after addition of stop reagent (cat# S5814; Sigma).
Human neutrophil elastase (HNE):DNA complexes. High binding 96 well ELISA microplates were incubated overnight at 4 °C with rabbit antihuman HNE 6 (cat# 481001; Calbiochem) in PBS. After blocking, plates were incubated overnight with 10% human plasma in blocking buffer, washed, and incubated for 1 h at room temperature with mouse anti-dsDNA mAb (clone 16-13; EMD Millipore), followed by anti-mouse IgG-HRP conjugate (cat#1706516; Bio-Rad, Hercules, CA). Procedure was completed as for MPO: DNA complexes.
Assessment of serum type I IFN activity. This was analyzed as previously described 56 . In brief, human HeLa cells (ATCC CCL2, ATCC collection, Manassas, VA) were grown in Dulbecco's modified Eagle's medium (cat# 11995-065; Gibco), supplemented with 10% FBS, 1 mM l-glutamine, and 1% penicillin-streptomycin at 37 °C in 5% CO 2 . Cells were obtained commercially and not tested for Mycoplasma. Cells were incubated for 8 h at 2 × 10 5 cells/well in the presence of serum (30%) or 1,000 U universal type I IFN-α (cat# 11200-1; PBL Assay Science, Piscataway, NJ). In some of the experiments, neutralizing antibodies to human IFN-α (clone MMHA-2; PBL Assay Science,), IFN-β (clone MMHB-2; PBL Assay Science,), or IFN-γ (cat# ab9657; Abcam) were also added during incubation. Cells were lysed and RNA extracted using Direct-zol RNA Miniprep kit (cat# 11-331; Zymo Research, Irvine, CA), and cDNA was prepared using the
